SCHEMBL351832

SCHEMBL351832

Fc1[c]cc2c(c1)OC(F)(F)O2

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.33
NOTUM Q6P988 1/20 0.33
CTNNB1 P35222 1/20 0.30
WNT3A P56704 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL351218 0.77 GPR3 (0.33) GPR3NOTUM
SCHEMBL350611 0.77 GPR3 (0.33) GPR3NOTUM
SCHEMBL1096709 0.77 GPR3 (0.33) GPR3NOTUM
SCHEMBL349055 0.72 P4HB (0.30) GPR3
SCHEMBL16026307 0.71 GPR3 (0.31) GPR3
SCHEMBL350075 0.67
SCHEMBL789550 0.67 CYP3A4 (0.35)
SCHEMBL1752066 0.64 AHR (0.48) GPR3NOTUMCTNNB1WNT3A
SCHEMBL8239476 0.64 TSHR (0.39) GPR3NOTUMCTNNB1WNT3A
SCHEMBL939408 0.64 GPR3 (0.38) GPR3NOTUMCTNNB1WNT3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120015981-A1 Active compound combinations BAYER CORPSCIENCE AG (DE) 2012-01-19 US disclosed
EP-2391214-A1 ACTIVE COMPOUND COMBINATIONS Bayer CropScience AG (DE) 2011-12-07 EP disclosed
EP-2391213-A1 ACTIVE COMPOUND COMBINATIONS Bayer CropScience AG (DE) 2011-12-07 EP disclosed
US-20110294855-A1 Active Compound Combinations BAYER CROPSCIENCE AG (DE) 2011-12-01 US disclosed
WO-2010086120-A1 ACTIVE COMPOUND COMBINATIONS BAYER CROPSCIENCE AG (DE) 2010-08-05 WO disclosed
WO-2010086109-A1 ACTIVE COMPOUND COMBINATIONS BAYER CROPSCIENCE AG (DE) 2010-08-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110294855-A1 Active Compound Combinations PFAS, AFF1, AFF2 GPR3 1447/4885NOTUM 45/4885CTNNB1 3767/4885
US-20120015981-A1 Active compound combinations PFAS, CBR3, AADAC GPR3 2154/4885NOTUM 23/4885CTNNB1 3985/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.